The role involves leading the strategy and execution of Direct-to-Patient promotions for Gilead's HIV long-acting treatment portfolio.
Base: $261,375.00 - $338,250.00; Bonus/Equity: Discretionary annual bonus and stock-based incentives eligible; Benefits: Medical, dental, vision, life insurance, and paid time off
Must-have
Nice-to-have
Not specified